Literature DB >> 27516050

[Delineation of organs at risk and dose constraints].

G Noël1, D Antoni2, I Barillot3, B Chauvet4.   

Abstract

From a review of literature, the objective of this paper is to define limits for delineation of organs at risk and dose constraints in this latter when radiotherapy is delivered with conventional fractionation or with hypofractionation as for stereotactic body radiation therapy.
Copyright © 2016. Published by Elsevier SAS.

Keywords:  Delineation; Dose; Délinéation; Organes à risque; Organs at risk; Radiotherapy; Radiothérapie; Stereotactic radiation therapy; Stéréotaxie

Mesh：

Year:  2016        PMID： 27516050     DOI： 10.1016/j.canrad.2016.07.032

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN： 1278-3218            Impact factor:   1.018


  6 in total

1.  Comparison of measured and calculated doses in a Rando phantom with a realistic lung radiotherapy treatment plan including heterogeneities.

Authors:  Serine Sarra Bouacid; Fayçal Kharfi; Fouad Boulakhssaim
Journal:  Radiat Environ Biophys       Date:  2018-09-11       Impact factor: 1.925

2.  Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers.

Authors:  Luc Ollivier; Jean Marc Guilloit; Mélanie Dos Santos; Laura Guillemette; Carmen Florescu; Che Mabubu M'vondo; Emmanuel Meyer; Marie-Pierre Galais; Stéphane Corbinais; Aurelie Parzy; Sharmini Varatharajah; Paul Lesueur
Journal:  Int J Colorectal Dis       Date:  2019-12-18       Impact factor: 2.571

3.  Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  Wafa Mnejja; Hend Daoud; Nejla Fourati; Tarek Sahnoun; Wicem Siala; Leila Farhat; Jamel Daoud
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-16

4.  Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review.

Authors:  Paul Sargos; Mame Daro Faye; Manon Bacci; Stéphane Supiot; Igor Latorzeff; David Azria; Tamim M Niazi; Te Vuong; Véronique Vendrely; Renaud de Crevoisier
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

5.  Dosimetrical and radiobiological approach to manage the dosimetric shift in the transition of dose calculation algorithm in radiation oncology: how to improve high quality treatment and avoid unexpected outcomes?

Authors:  Abdulhamid Chaikh; Jarkko Ojala; Catherine Khamphan; Robin Garcia; Jean Yves Giraud; Juliette Thariat; Jacques Balosso
Journal:  Radiat Oncol       Date:  2018-04-03       Impact factor: 3.481

6.  Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.

Authors:  T Kumar; A Schernberg; F Busato; M Laurans; I Fumagalli; I Dumas; E Deutsch; C Haie-Meder; C Chargari
Journal:  Cancer Manag Res       Date:  2019-07-08       Impact factor: 3.989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.